{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:59:31Z","timestamp":1790452771304,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.transproceed.2026.06.049","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:32:39Z","timestamp":1790451159000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Case of Graft-Versus-Host Disease in a Liver Transplant Recipient Receiving an HCV NAT Positive Organ: Does HCV NAT Matter?"],"prefix":"10.1016","author":[{"given":"Bryant B.","family":"Summers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2026.06.049_bib0001","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/lt.21082","article-title":"Recipient and donor factors influence the incidence of graft-versus-host disease in liver transplant patients","volume":"13","author":"Chan","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2026.06.049_bib0002","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/lt.21203","article-title":"Graft vs. host disease after liver transplantation: a new approach is needed","volume":"13","author":"Perri","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2026.06.049_bib0003","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1600-6143.2004.00406.x","article-title":"Acute graft versus host disease following liver transplantation: the enemy within","volume":"4","author":"Taylor","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2026.06.049_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2025.100942","article-title":"Graft-versus-host disease after liver transplantation: a global review of pathogenesis, diagnosis, and treatment strategies","volume":"39","author":"Obana","year":"2025","journal-title":"Transplant Rev"},{"issue":"10","key":"10.1016\/j.transproceed.2026.06.049_bib0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood.2022015954","article-title":"How I diagnose and treat acute graft-versus-host disease after solid organ transplantation","volume":"141","author":"Cooper","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2026.06.049_bib0006","unstructured":"Jakafi (ruxolitinib). Package insert. Incyte Pharmaceuticals. 2011."},{"key":"10.1016\/j.transproceed.2026.06.049_bib0007","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/ajt.15579","article-title":"The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplant","volume":"20","author":"Jacobs","year":"2020","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2026.06.049_bib0008","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MOT.0000000000000651","article-title":"Balancing the risk and rewards of utilizing organs from Hepatitis C viremic donors","volume":"24","author":"Sise","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"issue":"12","key":"10.1016\/j.transproceed.2026.06.049_bib0009","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/phar.2742","article-title":"A systematic review of direct acting antiviral therapies in hepatitis C virus-negative liver transplant recipients of hepatitis C-viremic donors","volume":"42","author":"Snyder","year":"2022","journal-title":"Pharmacother"},{"key":"10.1016\/j.transproceed.2026.06.049_bib0010","unstructured":"Centre for Experimental Therapeutics (TherEx). Drug interactions. University of Liverpool Drug Interactions Group. [Accessed 16.04.26]. Available at: https:\/\/hep-druginteractions.org\/checker."},{"key":"10.1016\/j.transproceed.2026.06.049_bib0011","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1111\/ajt.13486","article-title":"The impact of infection on chronic allograft dysfunction and allograft survival after solid organ transplantation","volume":"15","author":"Martin-Gandul","year":"2015","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2026.06.049_bib0012","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1526924818781558","article-title":"Two cases and a review of Graft-versus-Host-disease and the role of hepatitis C treatment in liver transplant patients","volume":"28","author":"Advani","year":"2018","journal-title":"Prog Transplant"},{"key":"10.1016\/j.transproceed.2026.06.049_bib0013","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40262-023-01225-7","article-title":"Pharmacokinetics and pharmacodynamics of ruxolitinib: a review","volume":"62","author":"Appeldoorn","year":"2023","journal-title":"Clin Pharmacokinetics"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526004513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526004513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:32:41Z","timestamp":1790451161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526004513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":13,"alternative-id":["S0041134526004513"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.06.049","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Case of Graft-Versus-Host Disease in a Liver Transplant Recipient Receiving an HCV NAT Positive Organ: Does HCV NAT Matter?","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}